Oxaliplatin Alternatives Compared
Oxaliplatin | Ipilimumab | Xeloda (capecitabine) |
|
---|
Oxaliplatin | Ipilimumab | Xeloda (capecitabine) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Colorectal Cancer. Oxaliplatin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Melanoma - Metastatic, Melanoma, Malignant Pleural Mesothelioma, Renal Cell Carcinoma, Colorectal Cancer. Ipilimumab may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Colorectal Cancer, Breast Cancer - Metastatic, Pancreatic Cancer, Breast Cancer, Esophageal Carcinoma, Stomach Cancer. Xeloda may also be used for purposes not listed in this medication guide. View more |
Related suggestions Colorectal Cancer
Popular comparisons
|
|||||||||||||||
More about Oxaliplatin | More about Ipilimumab | More about Xeloda (capecitabine) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Oxaliplatin has an average rating of 4.0 out of 10 from a total of 5 ratings on Drugs.com. 20% of reviewers reported a positive effect, while 60% reported a negative effect. |
Ipilimumab has an average rating of 7.0 out of 10 from a total of 4 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 25% reported a negative effect. |
Xeloda has an average rating of 6.6 out of 10 from a total of 31 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic |
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Oxaliplatin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Xeloda prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Eloxatin | Yervoy |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
391 hours |
352.8 hours |
0.75 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 616 drugs are known to interact with Oxaliplatin:
|
A total of 483 drugs are known to interact with Ipilimumab:
|
A total of 284 drugs are known to interact with Xeloda:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
N/A |
April 30, 1998 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.